Kevin P Starr's Net Worth

$1.34 Billion

Who is Kevin P Starr?

Kevin P Starr has an estimated net worth of $1.34 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., Relay Therapeutics, Inc., Foundation Medicine, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., Jounce Therapeutics, Inc., Global Blood Therapeutics, Inc., ALNYLAM PHARMACEUTICALS, INC., AGIOS PHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Sage Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., ZAFGEN, INC., Allena Pharmaceuticals, Inc., and HUMAN GENOME SCIENCES INC.

SEC CIK

Kevin P Starr's CIK is 0001192603

Past Insider Trading and Trends

2015 was Kevin P Starr's most active year for acquiring shares with 43 total transactions. Kevin P Starr's most active month to acquire stocks was the month of May. 2015 was Kevin P Starr's most active year for disposing of shares, totalling 48 transactions. Kevin P Starr's most active month to dispose stocks was the month of October. 2018 saw Kevin P Starr paying a total of $4,079,104.60 for 12,374,669 shares, this is the most they've acquired in one year. In 2021 Kevin P Starr cashed out on 21,434,231 shares for a total of $322,683,542.21, their largest year based on trade value.